Coldstream Capital Management Inc Prothena Corp Public LTD CO Put Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PRTA
# of Institutions
187Shares Held
43.6MCall Options Held
251KPut Options Held
79.2K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$77.8 Million11.27% of portfolio
-
Wellington Management Group LLP Boston, MA5.2MShares$34.9 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$25.9 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.46MShares$23.2 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$14.8 Million0.41% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $315M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...